We are live on ! Find out more
VTVT icon

vTv Therapeutics
VTVT

35 hedge funds and large institutions have $24.4M invested in vTv Therapeutics in 2016 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 15 increasing their positions, 6 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 6

1% more capital invested

Capital invested by funds: $24.1M → $24.4M (+$304K)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

15% less funds holding

Funds holding: 41 → 35 (-6)

86% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 7

Holders
35
Holders Change
-6
Holders Change %
-14.63%
% of All Funds
0.93%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
1
Increased
15
Reduced
6
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BFA
BlackRock Fund Advisors
California
+$245K
2
Ameriprise
Ameriprise
Minnesota
+$136K
3
State Street
State Street
Massachusetts
+$132K
4
Northern Trust
Northern Trust
Illinois
+$123K
5
BIT
BlackRock Institutional Trust
California
+$104K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$1.48M
2
PSC
Piper Sandler & Co
Minnesota
-$1.01M
3
UBS AM
UBS AM
Illinois
-$507K
4
FCM
Farallon Capital Management
California
-$353K
5
OAM
Oxford Asset Management
United Kingdom
-$119K
Name Holding Trade Value Shares
Change 		Change in
Stake
NFA
26
Nationwide Fund Advisors
Ohio
$28K – – –
AIG
27
American International Group
New York
$25.5K +$5.29K +23 +26%
New York State Common Retirement Fund
28
New York State Common Retirement Fund
New York
$25K – – –
SO
29
STRS Ohio
Ohio
$11K – – –
Manulife (Manufacturers Life Insurance)
30
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$8K -$7.36K -32 -49%
Deutsche Bank
31
Deutsche Bank
Germany
$7K +$1.38K +6 +21%
BJ
32
BlackRock Japan
Japan
$4K +$2.76K +12 +171%
BNP Paribas Financial Markets
33
BNP Paribas Financial Markets
France
$2.25K +$2.3K +10 New
Bank of America
34
Bank of America
North Carolina
$2K +$690 +3 +100%
BlackRock
35
BlackRock
New York
$1K – – –
Millennium Management
36
Millennium Management
New York
– -$1.48M -7,165 Closed
FCM
37
Farallon Capital Management
California
– -$353K -1,709 Closed
OAM
38
Oxford Asset Management
United Kingdom
– -$119K -575 Closed
Citigroup
39
Citigroup
New York
– -$22K -107 Closed
TRCT
40
Tower Research Capital (TRC)
New York
– -$11K -54 Closed
QCG
41
Quadrant Capital Group
Ohio
– -$3K -19 Closed
Wells Fargo
42
Wells Fargo
California
– -$3K -16 Closed
1
2

VTVT Hedge Fund Activity: Q2 2016 in Review

35 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in vTv Therapeutics (VTVT) for Q2 2016, worth a combined $24.4M — up 1.3% from $24.1M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of VTVT and 1 opened new positions — a net loss of 6 holders — while 6 trimmed existing stakes and 15 added.

The largest buyer was BlackRock Fund Advisors, adding an estimated $245K. The largest seller was Millennium Management, exiting entirely with an estimated $1.48M sold.

  • 35 institutional investors held vTv Therapeutics (VTVT) as of Q2 2016, down from 41 in Q1 2016.
  • Funds reported $24.4M of vTv Therapeutics stock for Q2 2016, up 1.3% quarter-over-quarter.
  • 1 fund opened new vTv Therapeutics positions in Q2 2016 and 7 closed out, a net change of -6 holders.
  • The largest vTv Therapeutics buyer in Q2 2016 was BlackRock Fund Advisors, an estimated $245K added.
  • The largest vTv Therapeutics seller in Q2 2016 was Millennium Management, an estimated $1.48M sold.

Based on aggregated 13F filings for Q2 2016.